Stratasys responds to COVID-19 pandemic by ramping up production of 3D-printed personal protection equipment

Stratasys responds to COVID-19 pandemic by ramping up production of 3D-printed personal protection equipment

Press releases may be edited for formatting or style | March 23, 2020 3D Printing

Stratasys has set up a web page where organizations can request 3D printed products to help with the crisis, offer 3D printing capacity, or request 3D printers or material for medical- or safety-related purposes. Visit www.stratasys.com/covid-19.

The company is also planning to respond to the crisis in additional ways. An initiative led by anesthesiology residents of Massachusetts General Hospital called the CoVent-19 Challenge is planning to ask engineers and designers to help develop a new rapidly deployable ventilator and other innovative solutions to the ventilator shortage, and Stratasys plans to support the challenge and promote it via its GrabCAD community of more than 7 million professional designers, engineers, manufacturers and students.

Midmark® Workstations & Telehealth - Enabling healthcare from anywhere

Midmark Workstations are made to order with customization that can assist with the integration of telehealth and other technology at the point of care, wherever that may be. See more>>>

About Stratasys
Stratasys is a global leader in additive manufacturing or 3D printing technology and is the manufacturer of FDM®, PolyJet™, and stereolithography 3D printers. The company’s technologies are used to create prototypes, manufacturing tools, and production parts for industries, including aerospace, automotive, healthcare, consumer products and education. For more than 30 years, Stratasys products have helped manufacturers reduce product-development time, cost, and time-to-market, as well as reduce or eliminate tooling costs and improve product quality. The Stratasys 3D printing ecosystem of solutions and expertise includes 3D printers, materials, software, expert services, and on-demand parts production.

Back to HCB News

You Must Be Logged In To Post A Comment